• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/16/21 3:50:11 PM ET
    $SCPE
    Business Services
    Finance
    Get the next $SCPE alert in real time by email
    SC 13G 1 d131680dsc13g.htm SC 13G SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No.     )*

     

     

    SC Health Corp.

    (Name of Issuer)

    Class A Ordinary Shares, $0.0001 par value per share

    (Title of Class of Securities)

    G78516 203

    (CUSIP Number)

    December 31, 2020

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     


      1    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      Perceptive Advisors LLC

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      SOLE VOTING POWER

     

      0

       6   

      SHARED VOTING POWER

     

      1,000,000

       7   

      SOLE DISPOSITIVE POWER

     

      0

       8   

      SHARED DISPOSITIVE POWER

     

      1,000,000

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,000,000

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      5.8%

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IA


      1    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      Joseph Edelman

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      United States of America

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      SOLE VOTING POWER

     

      0

       6   

      SHARED VOTING POWER

     

      1,000,000

       7   

      SOLE DISPOSITIVE POWER

     

      0

       8   

      SHARED DISPOSITIVE POWER

     

      1,000,000

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,000,000

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      5.8%

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IN


      1    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      Perceptive Life Sciences Master Fund, Ltd.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Cayman Islands

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      SOLE VOTING POWER

     

      0

       6   

      SHARED VOTING POWER

     

      1,000,000

       7   

      SOLE DISPOSITIVE POWER

     

      0

       8   

      SHARED DISPOSITIVE POWER

     

      1,000,000

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,000,000

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      5.8%

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      CO


    Item 1(a). Name of Issuer:

    SC Health Corporation (the “Issuer”)

    Item 1(b). Address of Issuer’s Principal Executive Offices:

    108 Robinson Road #10-00, Singapore, 068900

    Item 2(a). Names of Persons Filing:

    The names of the persons filing this report (collectively, the “Reporting Persons”) are:

    Perceptive Advisors LLC (“Perceptive Advisors”)

    Joseph Edelman (“Mr. Edelman”)

    Perceptive Life Sciences Master Fund, Ltd. (the “Master Fund”)

    Item 2(b). Address of Principal Business Office or, if None, Residence:

    The address of the principal business office of each of the Reporting Persons is:

    51 Astor Place, 10th Floor

    New York, NY 10003

    Item 2(c). Citizenship:

    Perceptive Advisors is a Delaware limited liability company

    Mr. Edelman is a United States citizen

    The Master Fund is a Cayman Islands corporation

    Item 2(d). Title of Class of Securities:

    Class A ordinary shares, $0.0001 par value per share (“Class A Ordinary Shares”)

    Item 2(e). CUSIP Number:

    G78516 203

    Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    Not applicable.

    Item 4. Ownership.

    The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G. The ownership percentages reported are based on 20,320,426 outstanding shares of Class A Ordinary Shares, as reported in the Issuer’s Form 10-Q filed on November 12, 2020.


    The Master Fund directly holds 1,000,000 Class A Ordinary Shares. Perceptive Advisors serves as the investment manager to the Master Fund and may be deemed to beneficially own such shares. Mr. Edelman is the managing member of Perceptive Advisors and may be deemed to beneficially own such shares.

     

    Item

    5. Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

     

    Item

    6. Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not applicable.

     

    Item

    8. Identification and Classification of Members of the Group.

    Not applicable.

     

    Item

    9. Notice of Dissolution of Group.

    Not applicable.

     

    Item

    10. Certification.

    Not applicable.

     


    SIGNATURE

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Date: February 16, 2021

     

    PERCEPTIVE ADVISORS LLC
    By:  

    /s/ Joseph Edelman

      Name: Joseph Edelman
      Title: Managing Member

    /s/ Joseph Edelman

    JOSEPH EDELMAN
    PERCEPTIVE LIFE SCIENCES MASTER FUND, LTD.
    By:   Perceptive Advisors LLC
    By:  

    /s/ Joseph Edelman

      Name: Joseph Edelman
      Title: Managing Member


    EXHIBIT 1

    AGREEMENT

    The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.

    Date: February 16, 2021

     

    PERCEPTIVE ADVISORS LLC
    By:  

    /s/ Joseph Edelman

      Name: Joseph Edelman
      Title: Managing Member

    /s/ Joseph Edelman

    JOSEPH EDELMAN
    PERCEPTIVE LIFE SCIENCES MASTER FUND, LTD.
    By:   Perceptive Advisors LLC
    By:  

    /s/ Joseph Edelman

      Name: Joseph Edelman
      Title: Managing Member
    Get the next $SCPE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SCPE

    DatePrice TargetRatingAnalyst
    6/30/2021$20.00Outperform
    Northland Capital Markets
    More analyst ratings

    $SCPE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital Markets initiated coverage on SC Health with a new price target

    Northland Capital Markets initiated coverage of SC Health with a rating of Outperform and set a new price target of $20.00

    6/30/21 8:29:35 AM ET
    $SCPE
    Business Services
    Finance

    $SCPE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Rockley Photonics Unveils End-to-end Digital Health Monitoring Solution Based on Spectrophotometer-on-a-chip Sensing Module

    Comprehensive "clinic-on-the-wrist" integration combining hardware, application firmware, and cloud analytics will accelerate deployment for customers and partners. Rockley Photonics, a leading global silicon photonics technology company, today revealed its complete full-stack, "clinic-on-the-wrist" digital health sensor system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210714005499/en/Wristband to be used in human studies (Photo: Business Wire) Rockley's sensor module and associated reference designs for consumer products integrate hardware and application firmware to enable wearable devices to monitor multiple biomarkers,

    7/14/21 7:00:00 AM ET
    $SCPE
    Business Services
    Finance

    Rockley Photonics Accelerates Plan to Revolutionize Consumer Health and Wellness Monitoring by Going Public via SC Health Corp.

    OXFORD, United Kingdom & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics, Ltd. (“the Company” or “Rockley”), a leading global supplier of integrated silicon photonic chips and modules across multiple markets, today announced that it has entered into a definitive agreement to combine with SC Health Corp. (“SC Health”) (NYSE: SCPE), a publicly traded special purpose acquisition company. The transaction will result in Rockley becoming a publicly traded company on the NYSE under the symbol RKLY and values the Company at a pro forma enterprise value of $1.2 billion. Transforming healthcare through revolutionary “clinic-on-the-wrist” monitoring technology The transaction will accel

    3/19/21 7:00:00 AM ET
    $SCPE
    Business Services
    Finance

    SC Health Corp. Enters into a Non-Binding Letter of Intent to Acquire a Next Generation Developer of Components & Modules for Consumer Health & Wellness Applications

    SINGAPORE--(BUSINESS WIRE)--SC Health Corp. (NYSE: SCPE) (the “Company”) announced today it has entered into a non-binding letter of intent (the “Letter of Intent”) with a next generation technology developer (the “Target”) for an initial business combination. The Target has developed a unique technology targeting consumer healthcare applications that delivers market-leading performance and accuracy. The Target is led by a world class management team with significant experience in leading innovative, high-growth companies in the sector. SC Health’s management team believes the Target is a compelling investment opportunity given its cutting-edge technology and commercial opportunity

    1/6/21 12:52:00 PM ET
    $SCPE
    Business Services
    Finance

    $SCPE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by SC Health Corporation

    4 - SC Health Corp (0001764301) (Issuer)

    8/13/21 12:20:52 PM ET
    $SCPE
    Business Services
    Finance

    SEC Form 4: Llc Capital, Glazer sold $144,050 worth of Class A ordinary shares (13,400 units at $10.75)

    4 - SC Health Corp (0001764301) (Issuer)

    2/22/21 6:14:03 PM ET
    $SCPE
    Business Services
    Finance

    SEC Form 4: Llc Capital, Glazer sold $1,307,194 worth of Class A ordinary shares (126,238 units at $10.36)

    4 - SC Health Corp (0001764301) (Issuer)

    1/20/21 7:12:25 PM ET
    $SCPE
    Business Services
    Finance

    $SCPE
    SEC Filings

    View All

    SEC Form 15-12B filed by SC Health Corporation

    15-12B - SC Health Corp (0001764301) (Filer)

    8/23/21 5:15:16 PM ET
    $SCPE
    Business Services
    Finance

    SC Health Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SC Health Corp (0001764301) (Filer)

    8/13/21 12:25:44 PM ET
    $SCPE
    Business Services
    Finance

    SEC Form 25-NSE filed by SC Health Corporation

    25-NSE - SC Health Corp (0001764301) (Subject)

    8/12/21 9:59:54 AM ET
    $SCPE
    Business Services
    Finance

    $SCPE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by SC Health Corporation (Amendment)

    SC 13G/A - SC Health Corp (0001764301) (Subject)

    8/9/21 10:45:12 AM ET
    $SCPE
    Business Services
    Finance

    SEC Form SC 13G filed by SC Health Corporation

    SC 13G - SC Health Corp (0001764301) (Subject)

    7/19/21 4:37:01 PM ET
    $SCPE
    Business Services
    Finance

    SEC Form SC 13G filed by SC Health Corporation

    SC 13G - SC Health Corp (0001764301) (Subject)

    7/19/21 9:38:11 AM ET
    $SCPE
    Business Services
    Finance